ArticleThe Journal of biological chemistry2026
Non-muscle tropomyosins inhibit myosin-19 and dynamically localize to mitochondrially associated actin filaments.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of Cardiomyopathic Mutations on the Cytoplasmic Tropomyosin Isoform Tpm1.7.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Myosin-19 (Myo19) is a mitochondrially localized actin-based motor important for regulating mitochondrial homeostasis, including the stabilization of mitochondrial-endoplasmic reticulum (mitoER) contact sites. Thus, proper regulation of Myo19 is likely required to maintain mitochondrial health and function, but little is known about regulatory mechanisms. Non-muscle tropomyosins are known to differentially regulate members of the myosin superfamily, leading us to hypothesize that tropomyosins may regulate Myo19-actin filament interactions. Here, we show that the interaction of Myo19 with actin filaments is inhibited by the association of Tropomyosin 3.1 (Tpm3.1) and 1.7 (Tpm1.7) with F-actin. This inhibition is highly cooperative, as both Tpm isoforms induce an all-or-none stalling of Myo19-driven filaments in in vitro gliding assays. In HeLa cells, Tpm3.1 is associated with actin filaments in close proximity to mitochondria. This localization is dynamic, as Tpm3.1 interacts with the mitochondrially-associated actin wave in interphase cells. These findings point toward a tropomyosin-based regulatory mechanism that spatially regulates Myo19 activity in a dynamic manner.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.